Literature DB >> 8665346

Disturbance of peripheral microvascular fluid permeability by the onset of atrioventricular asynchrony in patients with programmable pacemakers.

I R Mahy1, D M Lewis, A C Shore, M D Penney, L D Smith, J E Tooke.   

Abstract

BACKGROUND: In vitro and in vivo evidence suggests that atrial natriuretic peptide can enhance fluid flux from intravascular to extravascular compartments. The relevance of this to human pathophysiology remains unclear.
OBJECTIVES: To determine whether a central haemodynamic change associated with increased plasma concentrations of atrial natriuretic peptide produces detectable change in the capillary filtration coefficient in a peripheral microvascular bed. PATIENTS: 12 patients with programmable dual chamber permanent pacemakers.
METHODS: Calf capillary filtration coefficient (using a modified plethysmographic technique) and plasma atrial natriuretic peptide concentrations were measured during atrioventricular synchronous and ventricular pacing.
RESULTS: Atrioventricular asynchrony was associated with higher mean (SD) concentrations of atrial natriuretic peptide (231.9 (123.1) v 53.5 (38.8) pg/ml) and an increased mean (SD) calf capillary filtration coefficient (4.2 (1.1) v 3.6 (1.1) ml/min.mm Hg.100 ml x 10(-3)), but there was no correlation between the magnitude of the change in these variables in individual patients.
CONCLUSIONS: The peripheral capillary filtration coefficient may change in response to altered central haemodynamics. Atrial natriuretic peptide remains one potential candidate mechanism, but other factors are also likely to be involved.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8665346      PMCID: PMC484351          DOI: 10.1136/hrt.75.5.509

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  20 in total

1.  Radioimmunoassays of arginine vasopressin and atrial natriuretic peptide: application of a common protocol for plasma extraction using Sep-Pak C18 cartridges.

Authors:  M D Penney; D Hampton; D A Oleesky; C Livingstone; E Mulkerrin
Journal:  Ann Clin Biochem       Date:  1992-11       Impact factor: 2.057

2.  Microvascular effects of atrial natriuretic factor: interaction with alpha 1- and alpha 2-adrenoceptors.

Authors:  J E Faber; D R Gettes; D P Gianturco
Journal:  Circ Res       Date:  1988-08       Impact factor: 17.367

3.  Influence of pacing mode and rate on peripheral levels of atrial natriuretic peptide (ANP).

Authors:  B Noll; J Krappe; B Göke; B Maisch
Journal:  Pacing Clin Electrophysiol       Date:  1989-11       Impact factor: 1.976

4.  Atrial natriuretic peptide augments forearm capillary filtration in humans.

Authors:  L Groban; A W Cowley; T J Ebert
Journal:  Am J Physiol       Date:  1990-07

5.  Converting enzyme inhibition prevents the effects of atrial natriuretic factor on baroreflex responses in humans.

Authors:  M Volpe; G Lembo; G Condorelli; N De Luca; F Lamenza; C Indolfi; B Trimarco
Journal:  Circulation       Date:  1990-10       Impact factor: 29.690

6.  Total sympathetic activity and atrial natriuretic factor levels in VVI and DDD pacing with different atrioventricular delays during daily activity and exercise.

Authors:  G N Theodorakis; D T Kremastinos; M Markianos; E Livanis; G Karavolias; P K Toutouzas
Journal:  Eur Heart J       Date:  1992-11       Impact factor: 29.983

7.  Influence of AV synchrony on the plasma levels of atrial natriuretic peptide (ANP) in patients with total AV block.

Authors:  K Stangl; J Weil; K Seitz; M Laule; R Gerzer
Journal:  Pacing Clin Electrophysiol       Date:  1988-08       Impact factor: 1.976

8.  Arterial and venous effects of atrial natriuretic peptide in the human forearm.

Authors:  C J Doorenbos; G J Blauw; P van Brummelen
Journal:  Am J Hypertens       Date:  1991-04       Impact factor: 2.689

9.  Atrial natriuretic peptide increases human capillary filtration and venous distensibility.

Authors:  S Ando; T Imaizumi; S Harada; Y Hirooka; A Takeshita
Journal:  J Hypertens       Date:  1992-05       Impact factor: 4.844

10.  Hemodynamic, renal, and hormonal responses to incremental ANF infusions in humans.

Authors:  L Groban; T J Ebert; D U Kreis; M M Skelton; D M Van Wynsberghe; A W Cowley
Journal:  Am J Physiol       Date:  1989-05
View more
  1 in total

Review 1.  Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricular block.

Authors:  J Dretzke; W D Toff; G Y H Lip; J Raftery; A Fry-Smith; R Taylor
Journal:  Cochrane Database Syst Rev       Date:  2004
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.